News and Updates

We officially launched DayDrop® Artificial Tears during the Lebanese Ophthalmology Society Congress 2025.

This new eye drop uses a unique triple composition of Ectoine, Hyaluronic Acid & Carboxyme-Thylcellulose. This allows for sustained release of Ectoine over 12 hours, enabling the patient prolonged relief. While HA & CMC combine to increase the retention time of the drop on the ocular surface.